Radiotherapeutic Strategies in Management of Brain Metastasis
Brain metastasis may occur in 10-30% of all cancer patients, and the prognosis is generally poor, with median survival of only a few months. Treatments can vary widely, ranging from close observation to multimodality therapy including surgery, radiation and even chemotherapy. An understanding of the radiotherapy treatment options should help physicians in managing the overall care of their patients.
This activity is targeted to radiation oncologists, medical oncologists, surgical oncologists, neuro-oncologists, family medicine, generalists, radiation therapists, residents, and medical students.
At the conclusion of this activity, the participant should be able to:
- Describe the radiotherapeutic treatment options and survival outcomes for brain metastasis
- Explain the prognostic indicators and side effects that may impact patient response to treatment and quality of life
- Make appropriate treatment recommendations based on understanding of patient prognosis
- Discuss the emerging treatment technologies
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The University of Texas Southwestern Medical Center designates this enduring material activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 AMA
- 0.50 Attendance